VPAG and Older Medicines

VPAG and Older Medicines

VPAG and Older Medicines The Department of Health and Social Care DHSC has for many years being receiving a rebate from the manufacturers of branded prescribed drugs. This is intended to keep a cap on the growth in the medicines bill whilst allowing manufacturers to...
Are generics cheaper in England than the three devolved nations?

Are generics cheaper in England than the three devolved nations?

WaveData’s MD, Charles Joynson looks at generic products sold in England, Scotland, Northern Ireland, and Wales, in August, September and October of this year, focusing in on the top 500 most commonly advertised products. We only included products which were...
Does competition drive lower prices?

Does competition drive lower prices?

Wavedata looked at the average prices of generic products sold to pharmacies and dispensing doctors between August and October 2023 and compared this with the number of price list offers for the same products in the same time period. It would seem sensible to assume...
Typical and atypical long term pricing after loss of exclusivity

Typical and atypical long term pricing after loss of exclusivity

The first generic versions of Zonisamide Caps 25mg 14 were launched after loss of exclusivity in November 2015. However, in the run-up to this, the prices being offered to pharmacists and dispensing doctors for the brand declined from about £8.00 to about £7.40. This...
Eplerenone Tabs unstable long term pricing

Eplerenone Tabs unstable long term pricing

Eplerenone Tabs were launched in September 2014 after the loss of exclusivity of Pfizer’s Inspra brand. Eplerenone is one of those products which is subject to regular price bounces, concessions and shortages. Each of the two packs has experienced three price bounces...
Are concessions and shortages caused by the DHSC?

Are concessions and shortages caused by the DHSC?

It would seem sensible to assume that profitable products are less likely to suffer shortages, concessions and price spikes than products where profit is hard to come by. Charles Joynson, WaveData MD, compared the reimbursement price and the average market price for...